{"schema_version":"secwatch.filing_event.v1","accession":"0000832101-24-000004","form_type":"8-K","ticker":"IEX","cik":"0000832101","company_name":"IDEX CORP /DE/","filed_at":"2024-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.023746+00:00","generated_at":"2026-06-06T07:31:24.378344+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"IDEX Q4 sales -3%, adjusted EPS $1.83 (-9% YoY); FY2024 adjusted EPS guidance $8.15-$8.45","bullets":["Q4 sales $789M (-3%, -6% organic); GAAP EPS $1.43 (-16%), adjusted EPS $1.83 (-9%).","Full-year record sales $3.3B, record adjusted EPS $8.22 (+1%), record free cash flow $627M.","HST segment sales -11% YoY (-19% organic); adjusted EBITDA margin 25.8% (-450bps) on weak Life Sciences.","Acquired STC Material Solutions for $202M in Dec 2023; divested Novotema with $9.1M loss.","FY2024 outlook: organic sales growth 0-2%, GAAP EPS $7.15-$7.45, adjusted EPS $8.15-$8.45."],"urls":{"canonical":"https://secwatch.observer/filing/0000832101-24-000004","json":"https://secwatch.observer/filing/0000832101-24-000004.json","markdown":"https://secwatch.observer/filing/0000832101-24-000004.md","text":"https://secwatch.observer/filing/0000832101-24-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832101/000083210124000004/0000832101-24-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832101/000083210124000004/iex-20240206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T07:31:24.378344+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"642e87c18f0358b245e47489608af6cea3803231","claim":"IDEX CORP /DE/ reported financial results for the year ended December 31, 2023.","evidence_excerpt":"On February 6, 2024, IDEX Corporation (the \"Company\") issued a press release announcing financial results for the period ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832101/000083210124000004/0000832101-24-000004-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"907f3ea7ba6d53092a2a623838b4b3e37b0f6bd5","claim":"IDEX CORP /DE/ reported financial results for the quarter ended December 31, 2023.","evidence_excerpt":"On February 6, 2024, IDEX Corporation (the \"Company\") issued a press release announcing financial results for the period ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832101/000083210124000004/0000832101-24-000004-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}